Early FDG PET in Melanoma

Stopped low recruitment due to changing treatment landscape for subject population

Conditions

• Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma

Interventions

• RADIATION: FDG PET/CT imaging

Sponsor

Abramson Cancer Center at Penn Medicine